Formosa Laboratories, Inc.

Research Formosa Laboratories, Inc. (4746.TW) on Bullrun: market cap TWD 5.80B, P/E 12.3, dividend yield 6.6%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 5.80B; P/E is 12.3; dividend yield is 6.6%.

Peer valuation comparison

Latest P/E is 12.28x versus a Healthcare sector median of 21.8x (43.7% below).

Latest dividend yield is 6.61% versus a Healthcare sector median of 2.4% (175.4% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 5.80B12.36.2%3

Dividend history

Latest trailing dividend snapshot: annual dividend/share 3 TWD, yield 6.6%.

About Formosa Laboratories, Inc.

Formosa Laboratories, Inc., together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

ETFs that hold Formosa Laboratories, Inc.

US-listed ETFs

Formosa Laboratories, Inc. is held by 11 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:

ETFWeightFee
Avantis Emerging Markets Equity ETF (AVEM)<0.01%0.33%
Dimensional Emerging Core Equity Market ETF (DFAE)<0.01%0.29%
Dimensional Emerging Markets Core Equity 2 ETF (DFEM)<0.01%0.39%
Dimensional World ex U.S. Core Equity 2 ETF (DFAX)<0.01%0.28%
Dimensional Emerging Markets Value ETF (DFEV)0.01%0.43%
Avantis Emerging Markets Value ETF (AVES)<0.01%0.36%
Avantis Emerging Markets Ex-China Equity ETF (AVXC)<0.01%0.33%
State Street SPDR S&P Emerging Markets Small Cap ETF (EWX)0.02%0.65%

Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Formosa Laboratories, Inc.'s market cap?

Formosa Laboratories, Inc.'s market capitalization is TWD 5.80B.

What is Formosa Laboratories, Inc.'s P/E ratio?

Formosa Laboratories, Inc.'s price-to-earnings (P/E) ratio is 12.3.

Does Formosa Laboratories, Inc. pay a dividend?

Formosa Laboratories, Inc. has a dividend yield of 6.6%.

What does Formosa Laboratories, Inc. do?

Formosa Laboratories, Inc., together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.